135 related articles for article (PubMed ID: 335592)
1. Orthotopic skin graft survival in rats that have harbored skin implants in the anterior chamber of the eye.
Rao DS; Grogan JB
Transplantation; 1977 Nov; 24(5):377-81. PubMed ID: 335592
[TBL] [Abstract][Full Text] [Related]
2. Antigen nonspecific rejection of allogeneic skin implants in the anterior chamber of sensitized rats.
Grogan JB
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):501-10. PubMed ID: 2579928
[TBL] [Abstract][Full Text] [Related]
3. Suppressed cellular cytotoxic response in rats bearing skin implants in the anterior chamber of the eye.
Grogan JB
Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1390-6. PubMed ID: 3301732
[TBL] [Abstract][Full Text] [Related]
4. Host response to allogeneic implants in the anterior chamber of the rat eye.
Vessella RL; Raju S; Cockrell JV; Grogan JB
Invest Ophthalmol Vis Sci; 1978 Feb; 17(2):140-8. PubMed ID: 342439
[TBL] [Abstract][Full Text] [Related]
5. Suppression of graft-versus-host reactions in rats bearing implants in the anterior chamber of the eye.
Subba Rao DS; Grogan JB
Transplantation; 1979 Feb; 27(2):75-8. PubMed ID: 37617
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of suppression in cyclophosphamide-treated rats bearing allogeneic skin implants in the anterior chamber of the eye.
Grogan JB; Subba Rao DS; Henry SE
Invest Ophthalmol Vis Sci; 1985 Sep; 26(9):1230-5. PubMed ID: 3897115
[TBL] [Abstract][Full Text] [Related]
7. A reconsideration of immunological privilege within the anterior chamber of the eye.
Kaplan HJ; Stevens TR
Transplantation; 1975 Apr; 19(4):203-9. PubMed ID: 1098234
[TBL] [Abstract][Full Text] [Related]
8. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
[TBL] [Abstract][Full Text] [Related]
9. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
Towpik E; Kupiec-Weglinski JW; Schneider TM; Tyler D; Padberg W; Araneda D; Tilney NL
Transplantation; 1985 Dec; 40(6):714-8. PubMed ID: 3907046
[TBL] [Abstract][Full Text] [Related]
11. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness.
Langrehr JM; Hoffman RA; Demetris AJ; Lee KK; Neuhaus P; Wren SM; Ildstad ST; Schraut WH
Transplantation; 1992 Sep; 54(3):505-10. PubMed ID: 1384185
[TBL] [Abstract][Full Text] [Related]
12. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
Yamashita K; Masunaga T; Yanagida N; Takehara M; Hashimoto T; Kobayashi T; Echizenya H; Hua N; Fujita M; Murakami M; Furukawa H; Uede T; Todo S
Transplantation; 2003 Oct; 76(7):1089-96. PubMed ID: 14557758
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
Ruiz P; Fuller J; Sanfilippo F
Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of orthotopic bowel allografts in the rat treated with short-term low-dose cyclosporine.
Shimazu R; Grogan JB; Raju S
Transplantation; 1988 Nov; 46(5):673-7. PubMed ID: 3057687
[TBL] [Abstract][Full Text] [Related]
15. Immunologic study of the brain as a privileged site.
Raju S; Grogan JB
Transplant Proc; 1977 Mar; 9(1):1187-91. PubMed ID: 141123
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
Gorczynski RM; Fu XM; Issekutz T; Cohen Z
Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
[TBL] [Abstract][Full Text] [Related]
17. In vitro correlates of rejection. II. Rat mixed lymphocyte reactivity in vitro and cardiac allograft acute rejection, hyperacute or accelerated rejection, and prolongation by active immunization.
Guttmann RD
Transplantation; 1977 Feb; 23(2):153-7. PubMed ID: 138229
[TBL] [Abstract][Full Text] [Related]
18. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
Lin H; Bolling SF; Linsley PS; Wei RQ; Gordon D; Thompson CB; Turka LA
J Exp Med; 1993 Nov; 178(5):1801-6. PubMed ID: 8228826
[TBL] [Abstract][Full Text] [Related]
19. The anterior chamber of the eye: a sensitive site for the detection of cross-reacting alloantigens.
Vessella RL; Grogan JB; Raju S; Cockrell JV
J Surg Res; 1977 Jan; 22(1):1-4. PubMed ID: 319295
[No Abstract] [Full Text] [Related]
20. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
